Find Safinamide Mesylate manufacturers, exporters & distributors on PharmaCompass

Safinamide

Safinamide

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

25 API Suppliers, 11 USDMF, 2 JDMF, 1 EU WC, 4 KDMF, 6 NDC API, 19 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Formulations

22 Dossiers, 8 FDA Orange Book, 12 Europe, 2 Australia

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 50MG BASE

TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 15 Kerry, 10 Corel Pharma Chem, 9 Roquette, 8 Microlex e.U, 8 Sigachi Industries, 6 Gangwal Chemicals, 6 Seppic, 6 Lonza Capsugel, 5 Gangwal Healthcare, 5 Ideal Cures Pvt Ltd, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Kima Chemical, 2 The Dow Chemical Company, 2 Vasa Pharmachem, 2 Prachin Chemical, 2 DFE Pharma, 1 SPI Pharma, 1 Pharmatrans-Sanaq, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 1 ACG Worldwide, 1 Nanjing Well Pharmaceutical

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 22 Fillers, Diluents & Binders, 20 Controlled & Modified Release, 12 Lubricants & Glidants, 11 Thickeners and Stabilizers, 11 Direct Compression, 8 Film Formers & Plasticizers, 7 Disintegrants & Superdisintegrants, 7 Granulation, 6 Co-Processed Excipients, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 3 Chewable & Orodispersible Aids, 3 Emulsifying Agents, 2 Coloring Agents, 2 Rheology Modifiers, 1 Solubilizers, 1 Topical

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 10 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

PATENTS

6 US Patents

6 US Patents

DIGITAL CONTENT

33 News

33 News

Product Search

API SUPPLIERS

API Suppliers

US DMFs Filed

CEP/COS Certifications

JDMFs Filed

Other Certificates

Other Suppliers

API REF. PRICE (USD / KG)

2,558

API Market Place

INTERMEDIATES

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

27.00

Annual Reports

FDF Market Place

EXCIPIENTS

102

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

Other Listed Suppliers

SERVICES

Also known as: 202825-46-5, Safinamide mesilate, (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide methanesulfonate, Pnu-151774e, Nw-1015, Safinamide (mesylate)

Molecular Formula

C₁₈H₂₃FN₂O₅S

Molecular Weight

398.5 g/mol

InChI Key

YKOCHIUQOBQIAC-YDALLXLXSA-N

FDA UNII

YS90V3DTX0

1 2D Structure

Safinamide

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide;methanesulfonic acid

2.1.2 InChI

InChI=1S/C17H19FN2O2.CH4O3S/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14;1-5(2,3)4/h2-9,12,20H,10-11H2,1H3,(H2,19,21);1H3,(H,2,3,4)/t12-;/m0./s1

2.1.3 InChI Key

YKOCHIUQOBQIAC-YDALLXLXSA-N

2.1.4 Canonical SMILES

CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O

2.1.5 Isomeric SMILES

C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O

2.2 Other Identifiers

2.2.1 UNII

YS90V3DTX0

2.3 Synonyms

2.3.1 MeSH Synonyms

1. (s)-2-((4-(3-fluorobenzoxy)benzyl)amino)propanamide

2. 2-(4-(3-fluorobenzyloxy)benzylamino)propionamide

3. Fbap Methanesulfonate

4. Fce 26743

5. Fce 28073

6. Fce-26743

7. Fce-28073

8. Nw-1015

9. Pnu 151774e

10. Pnu-151774e

11. Safinamide

12. Safinamide Methanesulfonate

13. Xadago

2.3.2 Depositor-Supplied Synonyms

1. 202825-46-5

2. Safinamide Mesilate

3. (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide Methanesulfonate

4. Pnu-151774e

5. Nw-1015

6. Safinamide (mesylate)

7. Safinamide Methanesulfonate

8. Pnu 151774e

9. Safinamide Mesylate [usan]

10. Fce-28073

11. Nw 1015

12. Safinamide Methansulfonate

13. Ys90v3dtx0

14. Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-, (2s)-, Methanesulfonate (1:1)

15. 202825-46-5 (mesylate)

16. Safinamide Mesilate (jan)

17. Safinamide Mesylate (usan)

18. Safinamide Mesilate [jan]

19. (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)-amino)propanamide Methanesulfonate

20. Chembl48582

21. (s)-2-[[4-[(3-fluorobenzyl)oxy]benzyl]amino]propanamide Methanesulfonate

22. Unii-ys90v3dtx0

23. Fce-28073(r-isomer)

24. Safinamidemesylate

25. Equfina (tn)

26. Xadago (tn)

27. Safinamide Mesylate Salt

28. Emd 1195686 Mesylate

29. Mls006010740

30. Schembl1665715

31. Dtxsid80942414

32. Hms3884o17

33. Safinamide Mesylate (fce28073)

34. Amy38833

35. Bcp16018

36. Ex-a2640

37. Hy-70057a

38. Mfcd15145475

39. S1472

40. Safinamide Mesilate [who-dd]

41. Akos015902297

42. Ccg-268636

43. Safinamide Methanesulfonate [mi]

44. Safinamide Mesylate [orange Book]

45. Ac-27739

46. As-75602

47. Pnu-151774e,fce28073

48. Smr004701699

49. Safinamide Mesylate Salt, >=98% (hplc)

50. Cs-0006742

51. Sw219452-1

52. D10191

53. J-013174

54. Q27294690

55. (s)-2[4-(3-fluorobenzyloxy)benzylamino]propanamide Methanesulfonate

56. (s)-(+)-2-(4-(3-fluorobenzyloxy) Benzylamino)propanamide, Methanesulfonate

57. (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamidemethanesulfonate

58. (s)-2-[4-(3-fluorobenzyloxy)benzylamino]propanamide Methanesulfonate

59. (2s)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide;methanesulfonic Acid

60. Propanamide, 2-(((4-((3-fluorophenyl)methoxy)phenyl)methyl)amino)-, (s)-, Monomethanesulfonate

2.4 Create Date

2005-08-09

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₂₃FN₂O₅S
Molecular Weight	398.5 g/mol
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	7
Exact Mass	398.13117117 g/mol
Monoisotopic Mass	398.13117117 g/mol
Topological Polar Surface Area	127 Å²
Heavy Atom Count	27
Formal Charge	0
Complexity	438
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Drug and Medication Information

4.1 Drug Indication

Xadago is indicated for the treatment of adult patients with idiopathic Parkinsons disease (PD) as add-on therapy to a stable dose of Levodopa (L-dopa) alone or in combination with other PD medicinal products in mid-to late-stage fluctuating patients.

5 Pharmacology and Biochemistry

5.1 FDA Pharmacological Classification

5.1.1 Pharmacological Classes

Monoamine Oxidase Type B Inhibitor [EPC]; Monoamine Oxidase-B Inhibitors [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]

5.2 ATC Code

N04B